Siemens Healthineers has formed a strategic relationship with interventional MRI technology developer Imricor Medical Systems aimed at improving the treatment of heart arrhythmia.
The firms are seeking to develop an integrated system that brings together the clinical benefits of real-time MRI with 3D-guided cardiac ablation. Siemens and Imricor believe the development of MRI-compatible devices that translate information on cardiac conduction, morphological substrates, and individual patient anatomy will lead to better treatment outcomes
Electrophysiologists could potentially use this approach to treat arrhythmia without radiation and to visualize soft-tissue information from MRI, according to the vendors.
